UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts

Human reproduction (Oxford), 2014-08, Vol.29 (8), p.1706-1711

2014

Volltextzugriff (PDF)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus

American journal of nephrology, 2017-01, Vol.46 (6), p.450-458

2017

Volltextzugriff (PDF)

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5650-5654

2012

Volltextzugriff (PDF)

Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive

Contraception (Stoneham), 2012-03, Vol.85 (3), p.235-239

2012

Volltextzugriff (PDF)

Synthetic Conjugated Estrogens-B and Postmenopausal Nocturnal Vasomotor Symptoms: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2012-01, Vol.119 (1), p.78-84

2012

Volltextzugriff (PDF)

Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women

Fertility and sterility, 2008-10, Vol.90 (4), p.1132-1138

2008

Volltextzugriff (PDF)

A Phase I/IIA Trial of Continuous Five-Day Infusion of Squalamine Lactate (MSI-1256F) Plus Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2003-09, Vol.9 (11), p.4108-4115

2003

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Squalamine, a Novel Antiangiogenic Agent, in Patients with Advanced Cancers

Clinical cancer research, 2001-12, Vol.7 (12), p.3912-3919

2001

Volltextzugriff (PDF)

Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus

BMC nephrology, 2015-04, Vol.16 (1), p.47, Article 47

2015

Volltextzugriff (PDF)

In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers

Diagnostic microbiology and infectious disease, 1999-09, Vol.35 (1), p.45-53

1999

Volltextzugriff (PDF)

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits

Vaccine, 2013-06, Vol.31 (28), p.2963-2971

2013

Volltextzugriff (PDF)

Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach

Menopause (New York, N.Y.), 2008-09, Vol.15 (5), p.885

2008

Volltextzugriff (PDF)

Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy

Menopause (New York, N.Y.), 2009-07, Vol.16 (4), p.735

2009

Volltextzugriff (PDF)

Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive

Contraception (Stoneham), 2009-05, Vol.79 (5), p.350-355

2009

Volltextzugriff (PDF)

Patients' choice of treatment in stage D prostate cancer

Urology (Ridgewood, N.J.), 1989-05, Vol.33 (5), p.57-62

1989

Volltextzugriff (PDF)

Erratum to “a multicenter, randomized study of an extended cycle oral contraceptive” [contraception 68 (2003) 89–96]

Contraception (Stoneham), 2004-02, Vol.69 (2), p.175-175

2004

Volltextzugriff (PDF)

Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo

Contraception (Stoneham), 2008-08, Vol.78 (2), p.113-119

2008

Volltextzugriff (PDF)

Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen

Contraception (Stoneham), 2005, Vol.71 (1), p.55-59

2005

Volltextzugriff (PDF)

Evaluation of the long-term safety of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo

Contraception (Stoneham), 2007-08, Vol.76 (2), p.172-172

2007

Volltextzugriff (PDF)

Bleeding patterns in users of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo compared to a conventional 28-day regimen

Contraception (Stoneham), 2007-08, Vol.76 (2), p.171-172

2007

Volltextzugriff (PDF)

A look at the long-term safety of an extended-regimen OC

The Journal of family practice, 2010-05, Vol.59 (5), p.E3-E3

2010

Volltextzugriff (PDF)

The impact of altering the hormone free interval on bleeding patterns in users of a 91-day extended regimen oral contraceptive

Contraception (Stoneham), 2007-08, Vol.76 (2), p.157-157

2007

Volltextzugriff (PDF)

Anti-Ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent Ischemia

Journal of the American College of Cardiology, 1991-03, Vol.17 (4), p.957-962

1991

Volltextzugriff (PDF)

Once-Daily Lisinopril Compared with Twice-Daily Captopril in the Treatment of Mild to Moderate Hypertension: Assessment of Office and Ambulatory Blood Pressures

Journal of clinical pharmacology, 1990-12, Vol.30 (12), p.1074-1080

1990

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Female
(17)
Adult
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Obstetrics & Gynecology
(10)
Middle Aged
(9)
Pharmacology. Drug Treatments
(9)
Obstetrics And Gynecology
(8)
Gynecology. Andrology. Obstetrics
(7)
Male
(7)
Aged
(6)
Double-Blind Method
(6)
Drug Administration Schedule
(5)
Adolescent
(4)
Birth Control
(4)
Ethinyl Estradiol - Administration & Dosage
(4)
Genital System. Reproduction
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive

Synthetic Conjugated Estrogens-B and Postmenopausal Nocturnal Vasomotor Symptoms: A Randomized Controlled Trial

Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women

A Phase I/IIA Trial of Continuous Five-Day Infusion of Squalamine Lactate (MSI-1256F) Plus Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer

A Phase I and Pharmacokinetic Study of Squalamine, a Novel Antiangiogenic Agent, in Patients with Advanced Cancers

Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus

In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits

Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy

Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive

Patients' choice of treatment in stage D prostate cancer

Erratum to “a multicenter, randomized study of an extended cycle oral contraceptive” [contraception 68 (2003) 89–96]

Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo

Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen

Evaluation of the long-term safety of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo

Bleeding patterns in users of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo compared to a conventional 28-day regimen

A look at the long-term safety of an extended-regimen OC

The impact of altering the hormone free interval on bleeding patterns in users of a 91-day extended regimen oral contraceptive

Anti-Ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent Ischemia

Once-Daily Lisinopril Compared with Twice-Daily Captopril in the Treatment of Mild to Moderate Hypertension: Assessment of Office and Ambulatory Blood Pressures

Suchergebnisse filtern